Aehr Test Systems (NASDAQ:AEHR) Shares Down 7.5% – Time to Sell?

Aehr Test Systems (NASDAQ:AEHR) shares fell 7.5% on Friday . The stock traded as low as $34.66 and last traded at $34.9460. 354,184 shares changed hands during mid-day trading, a decline of 77% from the average session volume of 1,507,860 shares. The stock had previously closed at $37.76.

Wall Street Analyst Weigh In

A number of research analysts recently weighed in on the company. Weiss Ratings reiterated a “sell (d)” rating on shares of Aehr Test Systems in a report on Wednesday, January 21st. Lake Street Capital started coverage on Aehr Test Systems in a report on Wednesday, December 17th. They issued a “buy” rating on the stock. Craig Hallum reaffirmed a “hold” rating on shares of Aehr Test Systems in a research note on Friday, January 9th. Zacks Research upgraded Aehr Test Systems from a “strong sell” rating to a “hold” rating in a report on Monday, December 8th. Finally, William Blair raised shares of Aehr Test Systems from a “market perform” rating to an “outperform” rating in a research report on Monday, March 2nd. Two equities research analysts have rated the stock with a Buy rating, two have assigned a Hold rating and one has issued a Sell rating to the company’s stock. Based on data from MarketBeat, the company presently has an average rating of “Hold” and a consensus target price of $21.00.

Aehr Test Systems Stock Performance

The company’s fifty day moving average is $32.31 and its two-hundred day moving average is $27.60. The firm has a market cap of $1.06 billion, a price-to-earnings ratio of -115.06 and a beta of 2.22.

Aehr Test Systems (NASDAQ:AEHR) last released its quarterly earnings data on Thursday, January 8th. The semiconductor company reported ($0.04) EPS for the quarter, beating the consensus estimate of ($0.08) by $0.04. The company had revenue of $9.88 million for the quarter, compared to analyst estimates of $11.45 million. Aehr Test Systems had a negative return on equity of 4.57% and a negative net margin of 16.63%. As a group, analysts forecast that Aehr Test Systems will post 0.1 earnings per share for the current fiscal year.

Insider Activity

In related news, Director Laura Oliphant sold 4,546 shares of the firm’s stock in a transaction dated Thursday, January 22nd. The stock was sold at an average price of $31.40, for a total transaction of $142,744.40. Following the sale, the director directly owned 18,432 shares in the company, valued at approximately $578,764.80. This trade represents a 19.78% decrease in their position. The sale was disclosed in a filing with the SEC, which can be accessed through this link. Also, Director Rhea J. Posedel sold 13,998 shares of the company’s stock in a transaction that occurred on Friday, February 13th. The stock was sold at an average price of $30.02, for a total value of $420,219.96. Following the completion of the transaction, the director owned 456,979 shares of the company’s stock, valued at approximately $13,718,509.58. This represents a 2.97% decrease in their position. The SEC filing for this sale provides additional information. Company insiders own 6.80% of the company’s stock.

Institutional Inflows and Outflows

Several institutional investors and hedge funds have recently made changes to their positions in AEHR. Millennium Management LLC increased its stake in Aehr Test Systems by 0.8% during the fourth quarter. Millennium Management LLC now owns 59,219 shares of the semiconductor company’s stock valued at $1,196,000 after purchasing an additional 492 shares during the last quarter. State of Wyoming lifted its position in shares of Aehr Test Systems by 26.7% in the 3rd quarter. State of Wyoming now owns 2,777 shares of the semiconductor company’s stock worth $84,000 after buying an additional 586 shares during the last quarter. Sunbelt Securities Inc. acquired a new position in shares of Aehr Test Systems in the 3rd quarter valued at about $27,000. Jones Financial Companies Lllp boosted its holdings in shares of Aehr Test Systems by 3,448.3% in the 3rd quarter. Jones Financial Companies Lllp now owns 1,029 shares of the semiconductor company’s stock valued at $31,000 after buying an additional 1,000 shares during the period. Finally, JPMorgan Chase & Co. grew its position in shares of Aehr Test Systems by 7.9% during the 2nd quarter. JPMorgan Chase & Co. now owns 15,576 shares of the semiconductor company’s stock valued at $201,000 after buying an additional 1,145 shares during the last quarter. 69.69% of the stock is currently owned by hedge funds and other institutional investors.

About Aehr Test Systems

Aehr Test Systems develops, manufactures and sells semiconductor test and burn-in equipment used by device manufacturers to ensure quality and reliability of integrated circuits. Its products are designed for wafer-level reliability assessment, functional test and stress screening of memory devices, system-on-chips, optical components and power semiconductors. By focusing on wafer-level burn-in and testing processes, the company helps reduce cost and improve yield for high-volume semiconductor production.

The company’s product portfolio includes FOX series wafer probe test and burn-in systems as well as ABTS burn-in ovens.